vs
Side-by-side financial comparison of MARKETWISE, INC. (MKTW) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
MARKETWISE, INC. is the larger business by last-quarter revenue ($83.4M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -14.4%). MARKETWISE, INC. produced more free cash flow last quarter ($45.6M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -12.5%).
MarketWise Inc. is a leading provider of investment research, financial market data, and wealth management education solutions. It serves both retail and institutional investors across North America, Europe, and the Asia-Pacific region, offering actionable market insights, portfolio analysis tools, and specialized multi-asset research.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
MKTW vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.4M | $75.5M |
| Net Profit | $1.9M | — |
| Gross Margin | 87.0% | 69.3% |
| Operating Margin | 15.8% | 22.7% |
| Net Margin | 2.3% | — |
| Revenue YoY | -14.4% | 27.7% |
| Net Profit YoY | -9.8% | — |
| EPS (diluted) | $0.79 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $83.4M | $75.5M | ||
| Q3 25 | $81.3M | $54.5M | ||
| Q2 25 | $80.0M | $52.4M | ||
| Q1 25 | $83.5M | $46.0M | ||
| Q4 24 | $97.5M | $59.1M | ||
| Q3 24 | $97.2M | $80.5M | ||
| Q2 24 | $105.0M | $47.1M | ||
| Q1 24 | $109.0M | $43.8M |
| Q4 25 | $1.9M | — | ||
| Q3 25 | $1.5M | $8.8M | ||
| Q2 25 | $1.3M | $5.9M | ||
| Q1 25 | $890.0K | $3.0M | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $1.7M | $20.3M | ||
| Q2 24 | $1.5M | $-4.5M | ||
| Q1 24 | $1.7M | $-4.8M |
| Q4 25 | 87.0% | 69.3% | ||
| Q3 25 | 87.0% | 77.7% | ||
| Q2 25 | 86.3% | 76.5% | ||
| Q1 25 | 85.7% | 77.1% | ||
| Q4 24 | 88.7% | 76.4% | ||
| Q3 24 | 86.7% | 63.9% | ||
| Q2 24 | 87.3% | 77.4% | ||
| Q1 24 | 87.7% | 75.5% |
| Q4 25 | 15.8% | 22.7% | ||
| Q3 25 | 21.9% | 17.6% | ||
| Q2 25 | 18.5% | 12.7% | ||
| Q1 25 | 20.1% | 8.7% | ||
| Q4 24 | 24.8% | 22.6% | ||
| Q3 24 | 22.5% | 27.4% | ||
| Q2 24 | 20.3% | -4.6% | ||
| Q1 24 | 19.8% | -5.3% |
| Q4 25 | 2.3% | — | ||
| Q3 25 | 1.9% | 16.2% | ||
| Q2 25 | 1.6% | 11.2% | ||
| Q1 25 | 1.1% | 6.5% | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 1.8% | 25.2% | ||
| Q2 24 | 1.5% | -9.6% | ||
| Q1 24 | 1.5% | -11.0% |
| Q4 25 | $0.79 | $0.26 | ||
| Q3 25 | $0.58 | $0.17 | ||
| Q2 25 | $0.53 | $0.12 | ||
| Q1 25 | $0.41 | $0.06 | ||
| Q4 24 | $1.06 | $0.40 | ||
| Q3 24 | $0.87 | $0.41 | ||
| Q2 24 | $0.80 | $-0.09 | ||
| Q1 24 | $0.85 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $70.1M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $-11.7M | $130.3M |
| Total Assets | $218.4M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.1M | $97.5M | ||
| Q3 25 | $50.5M | $94.4M | ||
| Q2 25 | $69.1M | $96.0M | ||
| Q1 25 | $79.2M | $93.2M | ||
| Q4 24 | $97.9M | $101.0M | ||
| Q3 24 | $94.1M | $96.7M | ||
| Q2 24 | $109.3M | $96.8M | ||
| Q1 24 | $131.2M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | $707.0K | $102.0M |
| Q4 25 | $-11.7M | $130.3M | ||
| Q3 25 | $-14.5M | $115.3M | ||
| Q2 25 | $-15.8M | $104.7M | ||
| Q1 25 | $-15.8M | $97.1M | ||
| Q4 24 | $-12.5M | $92.1M | ||
| Q3 24 | $-19.5M | $71.1M | ||
| Q2 24 | $-23.7M | $48.5M | ||
| Q1 24 | $-9.4M | $51.0M |
| Q4 25 | $218.4M | $216.3M | ||
| Q3 25 | $201.7M | $202.9M | ||
| Q2 25 | $211.8M | $194.9M | ||
| Q1 25 | $239.6M | $196.2M | ||
| Q4 24 | $259.5M | $213.3M | ||
| Q3 24 | $278.4M | $220.7M | ||
| Q2 24 | $315.3M | $205.0M | ||
| Q1 24 | $359.3M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.0M | $14.4M |
| Free Cash FlowOCF − Capex | $45.6M | $14.4M |
| FCF MarginFCF / Revenue | 54.6% | 19.1% |
| Capex IntensityCapex / Revenue | 0.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 23.84× | — |
| TTM Free Cash FlowTrailing 4 quarters | $67.1M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.0M | $14.4M | ||
| Q3 25 | $2.2M | $9.7M | ||
| Q2 25 | $17.8M | $14.1M | ||
| Q1 25 | $1.7M | $3.6M | ||
| Q4 24 | $-22.1M | $15.6M | ||
| Q3 24 | $-5.8M | $11.0M | ||
| Q2 24 | $-3.8M | $1.0M | ||
| Q1 24 | $-18.5M | $11.2M |
| Q4 25 | $45.6M | $14.4M | ||
| Q3 25 | $2.2M | $9.7M | ||
| Q2 25 | $17.7M | $14.1M | ||
| Q1 25 | $1.7M | $3.6M | ||
| Q4 24 | $-22.3M | $15.6M | ||
| Q3 24 | $-5.9M | $11.0M | ||
| Q2 24 | $-3.8M | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | 54.6% | 19.1% | ||
| Q3 25 | 2.7% | 17.7% | ||
| Q2 25 | 22.2% | 26.8% | ||
| Q1 25 | 2.0% | 7.7% | ||
| Q4 24 | -22.9% | 26.4% | ||
| Q3 24 | -6.0% | 13.7% | ||
| Q2 24 | -3.6% | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | 0.5% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
| Q4 25 | 23.84× | — | ||
| Q3 25 | 1.44× | 1.10× | ||
| Q2 25 | 13.76× | 2.41× | ||
| Q1 25 | 1.95× | 1.21× | ||
| Q4 24 | -10.36× | — | ||
| Q3 24 | -3.39× | 0.54× | ||
| Q2 24 | -2.46× | — | ||
| Q1 24 | -11.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
